You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 22, December 10, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Otolaryngology/ Head & Neck Surgery, Other
 •Pediatrics
 •Pediatrics, Other
 •Randomized Controlled Trial
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dexamethasone and Risk of Nausea and Vomiting and Postoperative Bleeding After Tonsillectomy in Children

A Randomized Trial

Christoph Czarnetzki, MD, MBA; Nadia Elia, MD, MSc; Christopher Lysakowski, MD; Lionel Dumont, MD; Basile N. Landis, MD; Roland Giger, MD; Pavel Dulguerov, MD; Jules Desmeules, MD; Martin R. Tramèr, MD, DPhil

JAMA. 2008;300(22):2621-2630.

Context  Dexamethasone is widely used to prevent postoperative nausea and vomiting (PONV) in pediatric tonsillectomy.

Objective  To assess whether dexamethasone dose-dependently reduces the risk of PONV at 24 hours after tonsillectomy.

Design, Setting, and Patients  Randomized placebo-controlled trial conducted among 215 children undergoing elective tonsillectomy at a major public teaching hospital in Switzerland from February 2005 to December 2007.

Interventions  Children were randomly assigned to receive dexamethasone (0.05, 0.15, or 0.5 mg/kg) or placebo intravenously after induction of anesthesia. Acetaminophen-codeine and ibuprofen were given as postoperative analgesia. Follow-up continued until the 10th postoperative day.

Main Outcome Measures  The primary end point was prevention of PONV at 24 hours; secondary end points were decrease in the need for ibuprofen at 24 hours and evaluation of adverse effects.

Results  At 24 hours, 24 of 54 participants who received placebo (44%; 95% confidence interval [CI], 31%-59%) had experienced PONV compared with 20 of 53 (38%; 95% CI, 25%-52%), 13 of 54 (24%; 95% CI, 13%-38%), and 6 of 52 (12%; 95% CI, 4%-23%) who received dexamethasone at 0.05, 0.15, and 0.5 mg/kg, respectively (P<.001 for linear trend). Children who received dexamethasone received significantly less ibuprofen. There were 26 postoperative bleeding episodes in 22 children. Two of 53 (4%; 95% CI, 0.5%-13%) children who received placebo had bleeding compared with 6 of 53 (11%; 95% CI, 4%-23%), 2 of 51 (4%; 95% CI, 0.5%-13%), and 12 of 50 (24%; 95% CI, 13%-38%) who received dexamethasone at 0.05, 0.15, and 0.5 mg/kg, respectively (P = .003). Dexamethasone, 0.5 mg/kg, was associated with the highest bleeding risk (adjusted relative risk, 6.80; 95% CI, 1.77-16.5). Eight children had to undergo emergency reoperation because of bleeding, all of whom had received dexamethasone. The trial was stopped early for safety reasons.

Conclusion  In this study of children undergoing tonsillectomy, dexamethasone decreased the risk of PONV dose dependently but was associated with an increased risk of postoperative bleeding.

Trial Registration  clinicaltrials.gov Identifier: NCT00403806


Author Affiliations: Divisions of Anesthesiology (Drs Czarnetzki, Elia, Lysakowski, Dumont, and Tramèr); Otolaryngology–Head and Neck Surgery (Drs Landis, Giger, and Dulguerov), and Clinical Pharmacology and Toxicology (Dr Desmeules), University Hospitals of Geneva, Institute of Social and Preventive Medicine (Dr Elia), and Medical Faculty, University of Geneva (Drs Dulguerov, Desmeules, and Tramèr), Geneva, Switzerland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Dirk Beutner and Caroline Koll
JAMA. 2009;301(17):1764.
EXTRACT | FULL TEXT  

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Jae Il Shin
JAMA. 2009;301(17):1764.
EXTRACT | FULL TEXT  

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Joel B. Gunter, J. Paul Willging, and Charles M. Myer, III
JAMA. 2009;301(17):1764-1765.
EXTRACT | FULL TEXT  

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children—Reply
Christoph Czarnetzki, Nadia Elia, and Martin R. Tramèr
JAMA. 2009;301(17):1765-1766.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Beutner and Koll
JAMA 2009;301:1764-1764.
FULL TEXT  

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Shin
JAMA 2009;301:1764-1764.
FULL TEXT  

Dexamethasone and Postoperative Bleeding After Tonsillectomy in Children
Gunter et al.
JAMA 2009;301:1764-1765.
FULL TEXT  

Acustimulation of P6: an antiemetic alternative with no risk of drug-induced side-effects
Apfel and Kinjo
Br J Anaesth 2009;102:585-587.
FULL TEXT  

Perioperative Dexamethasone in Tonsillectomy May Increase Postop Bleeding
Sanders
AAP Grand Rounds 2009;21:39-39.
FULL TEXT  

Dexamethasone Use During Tonsillectomy Increases Risk for Postoperative Bleeding
JWatch Pediatrics 2009;2009:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.